Europe

ExpreS2ion Biotechnologies, Cancer Research U.K. enter license agreement

Monday, June 10, 2013 11:35 AM

ExpreS²ion Biotechnologies has signed a research license agreement to provide the Protein Purification Facility at Cancer Research U.K.’s London Research Institute with access to its Drosophila Schneider-2 cell-based technology platform—ExpreS²—for protein production.

More... »

Cenix BioScience, Debiopharm Group to identify predictive biomarkers

Wednesday, May 29, 2013 10:47 AM

Cenix BioScience, a preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a global Swiss biopharmaceutical group of companies focused on prescription drugs that target unmet medical needs, including oncology and companion diagnostics, have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

More... »

PRA opens new facility in Wales, creates 100 graduate-level jobs

Friday, May 17, 2013 02:03 PM

PRA, a global CRO, has officially opened its new facility in Swansea, Wales. The expansion is being supported with $1.9 million business finance from the Welsh government.

More... »

Bayer to acquire Steigerwald Arzneimittelwerk

Friday, May 17, 2013 11:56 AM

Bayer has signed an agreement to acquire 100% of the shares of Steigerwald Arzneimittelwerk, a Darmstadt, Germany-based privately held pharmaceutical company specializing in pharmacy-only herbal medicines.

More... »

Chiltern appoints Niewel and Bull to senior positions

Thursday, May 16, 2013 08:00 AM

Chiltern International, a global CRO based in the U.K., has appointed Dr. Manuela Niewel as medical director and Lisa Bull as director of strategic partnerships.

More... »

Aesica, University of Nottingham to develop novel amide chemical synthesis technique

Wednesday, May 8, 2013 11:36 AM

Aesica, a global contract manufacturing organization, has formed a partnership with the University of Nottingham for the commercial development of alternative methods in amide bond synthesis.

More... »

EMA publishes initial list of medicines under additional monitoring

Friday, April 26, 2013 10:22 AM

The European Medicines Agency has published the initial list of medicines that are subject to additional monitoring, representing an important deliverable of the new European pharmacovigilance legislation.

More... »

MHRA prioritizes science and research support as part of new corporate plan

Wednesday, April 24, 2013 10:17 AM

The Medicines and Healthcare Products Regulatory Agency (MHRA) announced its aim to be a leading regulator on the world stage in supporting science and research as part of its new five-year corporate plan.

More... »

Man jailed in pre-clinical trial data scam case

Wednesday, April 24, 2013 09:49 AM

A man has been sentenced to three months in prison for altering pre-clinical trial data designed to support applications to perform clinical trials.

More... »

Auris Medical secures $50M Series C financing for inner ear

Wednesday, April 17, 2013 10:15 AM

Auris Medical, a Swiss biotechnology company focused on novel therapeutics for the treatment of inner ear disorders, has completed a $50 million Series C financing. Two leading venture capital firms, Sofinnova Ventures  of Menlo Park, Calif., and Sofinnova Partners of Paris, participated in the financing.

More... »